Surgepays is trading at $0.16, down -5.09%, amid broad market weakness and risk-off pressure on small-cap equities.
- The S&P 500, Nasdaq, and Dow are each down roughly 0.5% or more.
- Geopolitical tensions, higher oil prices, and renewed rate-hike concerns are weighing on smaller, higher-risk stocks.
- No new company-specific announcement dated August 31, 2026, was identified; recent coverage highlighted liquidity concerns after the second-quarter report.